BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, January 2, 2026
See today's BioWorld MedTech
Home
» Kona stakes claim in renal denervation space with WAVE IV clinical trial
To read the full story,
subscribe
or
sign in
.
Kona stakes claim in renal denervation space with WAVE IV clinical trial
Sep. 2, 2014
By
Omar Ford
Another company is staking its claim in developing a non-invasive approach toward treating hypertension. Kona Medical (Bellevue, Washington) is evaluating its Surround Sound Hypertension Therapy System through the WAVE IV clinical trial.
BioWorld MedTech